Kriya Therapeutics Stock

kriyatherapeutics.comHealthcareFounded: 2019Funding to Date: $458.18MM

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy.

Buy or sell Kriya Therapeutics stock Learn more about Kriya Therapeutics IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for Kriya Therapeutics.

Register Today

Kriya Therapeutics investors also invested in these private companies

Foresite Capital

Altos Labs, Mammoth Biosciences, Galileo Health, Inscripta, Kriya Therapeutics, Intarcia Therapeutics

Patient Square Capital

Kriya Therapeutics

QVT Financial LP

Kriya Therapeutics

Dexcel Pharma

Kriya Therapeutics

Woodline Partners

SmartNews, Kriya Therapeutics

Cam Capital

Kriya Therapeutics

Bluebird Ventures

Kriya Therapeutics

Team

Management Team

Shankar Ramaswamy, MD

Co-Founder & Chief Executive Officer

Nachi Gupta, MD, PhD

President, Technology

Melissa Rhodes, PhD, DABT

President, Research and Development

Neera Ravindran, MD

Chief Financial Officer

Ilise Lombardo, MD

President

Michele Stone, PhD

Chief Scientific Officer

Board Members

Jim Momtazee

Patient Square Capital

CR Sincock II

Transhuman Capital

Saira Ramasastry

Life Sciences Advisory

Roger Jeffs, PhD

Kriya Therapeutics

Neel Varshney, MD

Patient Square Capital

Keith Manchester, MD

Life Sciences for QVT Family Office

Other companies like Kriya Therapeutics in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Healthcare

Popular Topics

Popular Topics

Kriya Therapeutics Stock

Register for Details